My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    2.

    Differential expression of individual complement regulators in the brain and choroid plexus.

    Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P.

    Lab Invest. 1999 Oct;79(10):1247-59.PMID: 10532588 [PubMed - indexed for MEDLINE]Related articles

    3.

    Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.

    Christmas SE, de la Mata Espinosa CT, Halliday D, Buxton CA, Cummerson JA, Johnson PM.

    Immunology. 2006 Dec;119(4):522-8. Epub 2006 Sep 26.PMID: 16999828 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

    Gelderman KA, Zijlmans HJ, Vonk MJ, Gorter A.

    Gut. 2004 Apr;53(4):507-13.PMID: 15016744 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.

    van Beek J, van Meurs M, 't Hart BA, Brok HP, Neal JW, Chatagner A, Harris CL, Omidvar N, Morgan BP, Laman JD, Gasque P.

    J Immunol. 2005 Feb 15;174(4):2353-65.PMID: 15699172 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

    Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P.

    Am J Pathol. 2000 Sep;157(3):905-18.PMID: 10980130 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Expression of complement regulators and receptors on human NT2-N neurons--effect of hypoxia and reoxygenation.

    Pedersen ED, Frøyland E, Kvissel AK, Pharo AM, Skålhegg BS, Rootwelt T, Mollnes TE.

    Mol Immunol. 2007 Mar;44(9):2459-68. Epub 2006 Nov 20.PMID: 17116331 [PubMed - indexed for MEDLINE]Related articles

    8.

    Primary human hepatocytes are protected against complement by multiple regulators.

    Halme J, Sachse M, Vogel H, Giese T, Klar E, Kirschfink M.

    Mol Immunol. 2009 Jul;46(11-12):2284-9. Epub 2009 May 14.PMID: 19446335 [PubMed - indexed for MEDLINE]Related articles

    9.

    Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack.

    Zell S, Geis N, Rutz R, Schultz S, Giese T, Kirschfink M.

    Clin Exp Immunol. 2007 Dec;150(3):576-84. Epub 2007 Sep 28.PMID: 17903221 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.

    Ravindranath NM, Shuler C.

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Feb;103(2):231-9. Epub 2006 Oct 16.PMID: 17234541 [PubMed - indexed for MEDLINE]Related articles

    11.

    Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.

    Barros MM, Yamamoto M, Figueiredo MS, Cançado R, Kimura EY, Langhi DM Jr, Chiattone CS, Bordin JO.

    Transfusion. 2009 Jan;49(1):154-60. Epub 2008 Oct 2.PMID: 18954403 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression and modulation of RPE cell membrane complement regulatory proteins.

    Yang P, Tyrrell J, Han I, Jaffe GJ.

    Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3473-81. Epub 2009 Jan 24.PMID: 19168900 [PubMed - indexed for MEDLINE]Related articles

    14.

    Heterogeneous expression of CD59 on human Purkinje cells.

    Storstein A, Knudsen A, Bjørge L, Meri S, Vedeler C.

    Neurosci Lett. 2004 May 13;362(1):21-5.PMID: 15147772 [PubMed - indexed for MEDLINE]Related articles

    15.

    Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.

    Varela JC, Atkinson C, Woolson R, Keane TE, Tomlinson S.

    Int J Cancer. 2008 Sep 15;123(6):1357-63.PMID: 18561323 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Expression of complement regulatory proteins on human natural killer cell subsets.

    Wang L, Halliday D, Johnson PM, Christmas SE.

    Immunol Lett. 2007 Oct 15;112(2):104-9. Epub 2007 Aug 9.PMID: 17719652 [PubMed - indexed for MEDLINE]Related articles

    17.

    Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas.

    Ravindranath NM, Shuler C.

    J Oral Pathol Med. 2006 Oct;35(9):560-7.PMID: 16968237 [PubMed - indexed for MEDLINE]Related articles

    18.

    CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells.

    Elward K, Griffiths M, Mizuno M, Harris CL, Neal JW, Morgan BP, Gasque P.

    J Biol Chem. 2005 Oct 28;280(43):36342-54. Epub 2005 Aug 8.PMID: 16087667 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The C-terminus of complement factor H is essential for host cell protection.

    Józsi M, Oppermann M, Lambris JD, Zipfel PF.

    Mol Immunol. 2007 Apr;44(10):2697-706. Epub 2007 Jan 17.PMID: 17208302 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin's lymphoma.

    Dzietczenia J, Wróbel T, Mazur G, Poręba R, Jaźwiec B, Kuliczkowski K.

    Med Oncol. 2009 Aug 7. [Epub ahead of print]PMID: 19662541 [PubMed - as supplied by publisher]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk